Intranasal Delivery of Nerve Growth Factor in Neurodegenerative Diseases and Neurotrauma
Since the 1980s, the development of a pharmacology based on nerve growth factor (NGF) has been postulated for the therapy of Alzheimer’s disease (AD). This hypothesis was based on the rescuing effect of the neurotrophin on the cholinergic phenotype of the basal forebrain neurons, primarily compromis...
Saved in:
Main Authors: | Luigi Manni, Giorgio Conti, Antonio Chiaretti, Marzia Soligo |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/c61e5f160f2b4259aaf62ed2afadf5df |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Evolving Concept of Neuro-Thromboinflammation for Neurodegenerative Disorders and Neurotrauma: A Rationale for PAR1-Targeting Therapies
by: Barry W. Festoff, et al.
Published: (2021) -
Encapsulated Escitalopram and Paroxetine Intranasal Co-Administration: In Vitro/In Vivo Evaluation
by: Soraia Silva, et al.
Published: (2021) -
Immunomodulation induced by central nervous system‐related peptides as a therapeutic strategy for neurodegenerative disorders
by: María Laura Palumbo, et al.
Published: (2021) -
Reversed phase HPLC determination of zidovudine in rat plasma and its pharmacokinetics after a single intranasal dose administration
by: MAINARDES,RUBIANA M, et al.
Published: (2009) -
The Emerging Scenario of the Gut–Brain Axis: The Therapeutic Actions of the New Actor Kefir against Neurodegenerative Diseases
by: Thiago M. C. Pereira, et al.
Published: (2021)